Article
Rapid Genetic Testing for BRCA1 and BRCA2 Mutations at the Time of Breast Cancer Diagnosis: An Observational Study.
Annals of surgical oncology - 1 Apr 2021
Metcalfe Kelly A, Eisen Andrea, Poll Aletta, Candib Alexandra, McCready David, Cil Tulin, Wright Frances, Lerner-Ellis Jordan, McCuaig Jeanna, Graham Tracy, Sun Ping, Akbari Mohammad, Narod Steven A
Abstract excerpt
BACKGROUND: This study aimed to evaluate the impact of rapid genetic testing (RGT) for BRCA1 and BRCA2 at the time of breast cancer diagnosis on treatment choices. Bilateral mastectomy for the treatment of breast cancer in women with a BRCA1 or BRCA2 mutation offers a reduction in the risk of contralateral breast cancer. It is unclear whether offering RGT at the time of breast cancer diagnosis has an impact on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
